[go: up one dir, main page]

MXPA05008109A - Derivados de urea y tiourea. - Google Patents

Derivados de urea y tiourea.

Info

Publication number
MXPA05008109A
MXPA05008109A MXPA05008109A MXPA05008109A MXPA05008109A MX PA05008109 A MXPA05008109 A MX PA05008109A MX PA05008109 A MXPA05008109 A MX PA05008109A MX PA05008109 A MXPA05008109 A MX PA05008109A MX PA05008109 A MXPA05008109 A MX PA05008109A
Authority
MX
Mexico
Prior art keywords
urea
thiourea derivatives
moet
zene
exc
Prior art date
Application number
MXPA05008109A
Other languages
English (en)
Inventor
Yunlong Du Daniel
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of MXPA05008109A publication Critical patent/MXPA05008109A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/28—Antiandrogens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/06—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2
    • C07D311/08—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring
    • C07D311/14—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring substituted in position 6 and unsubstituted in position 7
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

La invencion se dirige a una nueva clase de compuestos quinolin-zeno y z-exc cromeno que han sido derivatizados en la posicion 6 con una urea o este resto de urea, y su uso como agentes antagonistas de los androgenos.
MXPA05008109A 2003-02-11 2004-01-30 Derivados de urea y tiourea. MXPA05008109A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US44640903P 2003-02-11 2003-02-11
PCT/IB2004/000295 WO2004072044A2 (en) 2003-02-11 2004-01-30 Urea and thiourea derivatives

Publications (1)

Publication Number Publication Date
MXPA05008109A true MXPA05008109A (es) 2005-09-21

Family

ID=32869502

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA05008109A MXPA05008109A (es) 2003-02-11 2004-01-30 Derivados de urea y tiourea.

Country Status (7)

Country Link
US (1) US7074933B2 (es)
EP (1) EP1603882A2 (es)
JP (1) JP2006517578A (es)
BR (1) BRPI0407354A (es)
CA (1) CA2515589A1 (es)
MX (1) MXPA05008109A (es)
WO (1) WO2004072044A2 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006029040A2 (en) * 2004-09-02 2006-03-16 Shih Charles C Y Methods and compositions for enhancing degradation of nuclear receptor transcription factors and uses thereof
GB0720061D0 (en) * 2007-10-13 2007-11-21 Finnen Michael Method & composition for the treatment of acne and sebum dependent pilosebaceous disorders
CN108148034B (zh) * 2018-01-12 2021-06-01 青岛农业大学 一类含氟取代脲基香豆素衍生物及其除草与杀菌用途

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5811947B2 (ja) * 1976-12-10 1983-03-05 大塚製薬株式会社 カルボスチリル誘導体
JPS58102936A (ja) * 1981-12-15 1983-06-18 Konishiroku Photo Ind Co Ltd ハロゲン化銀カラ−写真感光材料
JPS59164554A (ja) * 1983-03-08 1984-09-17 Fuji Photo Film Co Ltd ハロゲン化銀カラ−写真感光材料
US6017924A (en) 1996-06-27 2000-01-25 Ligand Pharmaceuticals Incorporated Androgen receptor modulator compounds and methods
US6667313B1 (en) 1999-08-27 2003-12-23 Ligand Pharmaceuticals Inc. 8-substituted-6-triflouromethyl-9-pyrido [3,2-G] quinoline compounds as androgen receptor modulators
DE60027443D1 (de) 1999-08-27 2006-05-24 Ligand Pharm Inc Androgenrezeptor-modulatorverbindungen und verfahren
US6566372B1 (en) * 1999-08-27 2003-05-20 Ligand Pharmaceuticals Incorporated Bicyclic androgen and progesterone receptor modulator compounds and methods

Also Published As

Publication number Publication date
EP1603882A2 (en) 2005-12-14
WO2004072044A2 (en) 2004-08-26
CA2515589A1 (en) 2004-08-26
US7074933B2 (en) 2006-07-11
WO2004072044A3 (en) 2004-11-11
US20040266820A1 (en) 2004-12-30
BRPI0407354A (pt) 2006-01-10
JP2006517578A (ja) 2006-07-27

Similar Documents

Publication Publication Date Title
MXPA03010134A (es) Derivados de ciclohexan-1-4-diamina sustituidos.
IL176571A0 (en) Substituted azole derivatives, compositions, and methods of use
MXPA04008772A (es) Composiciones de clorhidrato de naltrexona.
HN2003000285A (es) Nuevas quinazolinonas espirocondensadas y su uso como inhibidores de la fosfodiesterasa
ECSP12007067A (es) Derivados de quinazolinona útiles como antagonistas vanilloides
MXPA03006363A (es) Derivados de urea como antagonistas de integrinas alfa-4.
ZA200702131B (en) Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof l
DE60321722D1 (de) Derivate von aryl-chinazolin/aryl-2amino-phenyl-methanon zurförderung der freisetzung von parathormon
TW200716525A (en) Process for preparation of sulfamide derivatives
MXPA03010158A (es) Sulfonamidas.
MXPA05007605A (es) Antagonista del receptor de androgenos.
EP1551388A4 (en) COMPOUNDS USEFUL IN THE TREATMENT OF CANCER, COMPOSITIONS AND METHODS COMPRISING THE SAME
UA92730C2 (ru) Аналоги бензазола и их применение
PT1638943E (pt) Novos derivados de imidazoles, sua preparação e sua utilização como medicamento
SG151306A1 (en) Novel benzothiazoles and the use thereof as medicaments
MXPA05008109A (es) Derivados de urea y tiourea.
UY28917A1 (es) Derivados de tetrahidroisoquinolilsulfonamidas composiciones farmaceuticas y su uso terapeutico
PL364826A1 (en) Use of an isothiocyanate, a thiocyanate or a mixture thereof as depigmenting agent
BR0208221A (pt) Combinação de uma taxano e uma cinase dependente de ciclina
PL1898901T3 (pl) Stabilne postacie dawkowania spiro i dispiro 1, 2, 4-trioksolanowych związków przeciwmalarycznych
ATE410925T1 (de) Antibakterielle zusammensetzung
IL165942A0 (en) Acyloxypyrrolidine derivatives and use thereof as ligands of vib or both vib and via receptors
MXPA05006587A (es) Compuestos de tiazol como derivados de antagonistas del receptor de la integrina.
WO2004043366A3 (en) Sulfonamides
EP1617723A4 (en) BACTERIOPHAGE OF METHYLOBACTERIUM LYSE AND COMPOSITIONS AND USES THEREOF

Legal Events

Date Code Title Description
FA Abandonment or withdrawal